Clinical Trials Directory

Trials / Completed

CompletedNCT01286493

Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination

Immune Response After Booster Vaccination in HIV - Infected Patients Who Ever Received Rabies Primary Vaccination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Queen Saovabha Memorial Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Booster rabies vaccination in HIV - infected patients who have ever received rabies primary vaccination could improve their immune response to this kind of vaccine.

Detailed description

The investigators have learned from the previous studies that some HIV-infected patients especially those with low CD4+ T-lymphocyte count had poor antibody response to rabies vaccination. Because of the role of the memory B cell, the investigators hypothesized that primary rabies immunization in HIV-infected patients could rise rapid anamnestic antibody response to ones after booster vaccination in case of re-exposure of rabies occur despite of their immunocompromised state.

Conditions

Interventions

TypeNameDescription
BIOLOGICALrabies vaccines on day 0 and 3All subjects would receive conventional intramuscular booster rabies vaccination on day 0 and 3. Their blood would be drawn for rabies neutralizing antibody on day 0,7,14,30,90,180,360

Timeline

Start date
2011-02-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2011-01-31
Last updated
2015-11-18
Results posted
2014-06-04

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01286493. Inclusion in this directory is not an endorsement.

Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination (NCT01286493) · Clinical Trials Directory